IMNN insider transactions
Imunon Inc. (IMNN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for IMNN
- Executive Chairman of Board Tardugno Michael H was granted 4,410 shares, increasing direct ownership by 7% to 64,396 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 3 filed by new insider Blacher Joshua3 - Imunon, Inc. (0000749647) (Issuer)
- General Counsel and Corp Sec Eylward Susan was granted 920 shares and sold $1,730 worth of shares (920 units at $1.88) (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Chief Medical Officer Faller Douglas Vincent was granted 1,308 shares, increasing direct ownership by 6% to 23,204 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- President and CEO Lindborg Stacy was granted 2,534 shares, increasing direct ownership by 3% to 76,722 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Chief Medical Officer Faller Douglas Vincent was granted 21,896 shares (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- General Counsel and Corp Sec Eylward Susan was granted 14,696 shares and sold $20,674 worth of shares (11,800 units at $1.75) (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Executive Chairman of Board Tardugno Michael H was granted 42,519 shares, increasing direct ownership by 243% to 59,986 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- President and CEO Lindborg Stacy was granted 67,150 shares, increasing direct ownership by 954% to 74,188 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Executive Chairman of Board Tardugno Michael H was granted 4,629 shares, increasing direct ownership by 36% to 17,467 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- President and CEO Lindborg Stacy was granted 1,803 shares, increasing direct ownership by 34% to 7,038 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Executive Chairman of Board Tardugno Michael H was granted 4,089 shares, increasing direct ownership by 47% to 12,838 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- President and CEO Lindborg Stacy was granted 1,593 shares, increasing direct ownership by 44% to 5,235 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Executive Chairman of Board Tardugno Michael H was granted 3,484 shares, increasing direct ownership by 66% to 8,749 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Director Pellizzari Christine A was granted 5,557 shares, increasing direct ownership by 215% to 8,142 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Director Dentzer James E was granted 11,148 shares, increasing direct ownership by 292% to 14,963 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Director Braun Donald P was granted 5,011 shares, increasing direct ownership by 116% to 9,319 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Director Fritz Frederick J. was granted 10,330 shares, increasing direct ownership by 274% to 14,097 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- President and CEO Lindborg Stacy was granted 1,491 shares, increasing direct ownership by 69% to 3,642 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- New insider Church Jeffrey Wayne claimed ownership of 26 shares (SEC Form 3)3 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by CFO Bragg Kimberly4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Fritz Frederick J.4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Faller Douglas Vincent4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Pellizzari Christine A4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Braun Donald P4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Dentzer James E4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by President and CEO Lindborg Stacy4 - Imunon, Inc. (0000749647) (Issuer)
- President and CEO Lindborg Stacy converted options into 1,667 shares, increasing direct ownership by 87% to 3,584 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Director Dentzer James E was granted 3,318 shares (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Director Pellizzari Christine A was granted 2,248 shares (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Director Braun Donald P was granted 2,040 shares, increasing direct ownership by 120% to 3,747 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- Director Fritz Frederick J. was granted 3,161 shares, increasing direct ownership by 403% to 3,946 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by CFO Bragg Kimberly4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by President and CEO Lindborg Stacy4 - Imunon, Inc. (0000749647) (Issuer)
- New insider Bragg Kimberly claimed ownership of 20,400 shares (SEC Form 3)3 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Fritz Frederick J.4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Braun Donald P4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Dentzer James E4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Pellizzari Christine A4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by President and CEO Lindborg Stacy4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Faller Douglas Vincent4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 3 filed by new insider Faller Douglas Vincent3 - Imunon, Inc. (0000749647) (Issuer)
- Director Braun Donald P bought $29,480 worth of shares (25,000 units at $1.18), increasing direct ownership by 4,188% to 25,597 units (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H4 - Imunon, Inc. (0000749647) (Issuer)
- Amendment: SEC Form 4 filed by President and CEO Lindborg Stacy4/A - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Braun Donald P4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Pellizzari Christine A4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Dentzer James E4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by Director Fritz Frederick J.4 - Imunon, Inc. (0000749647) (Issuer)
- SEC Form 4 filed by President and CEO Lindborg Stacy4 - Imunon, Inc. (0000749647) (Issuer)